IIRC, the 'hacked/leaked' documents from the pharma co's a while back suggested manufacturing issues, resulting in less active componenets than desired. Plus if you double up, more profit.
IIRC, the 'hacked/leaked' documents from the pharma co's a while back suggested manufacturing issues, resulting in less active componenets than desired. Plus if you double up, more profit.